Circulating tumor cells: utopia or reality?
暂无分享,去创建一个
Vincenza Conteduca | V. Conteduca | R. Zamarchi | Michele Aieta | M. Aieta | L. Troiani | E. Rossi | Rita Zamarchi | Elisabetta Rossi | V. Condelli | Valentina Condelli | Laura Troiani
[1] Denis Wirtz,et al. The physics of cancer: the role of physical interactions and mechanical forces in metastasis , 2011, Nature Reviews Cancer.
[2] G Kvalheim,et al. Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. , 1999, Cytotherapy.
[3] G. Packham,et al. MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression , 2012, Biology of the cell.
[4] Peter Kuhn,et al. High speed detection of circulating tumor cells. , 2006, Biosensors & bioelectronics.
[5] V. Valero,et al. Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system , 2012, International journal of cancer.
[6] P. V. van Dam,et al. Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancer , 2009, British Journal of Cancer.
[7] G. Migliardi,et al. Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer , 2011, BMC Cancer.
[8] Real-time RT–PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer , 2006, British Journal of Cancer.
[9] Mehmet Toner,et al. Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer , 2010, Science Translational Medicine.
[10] Klaus Pantel,et al. Circulating tumour cells in cancer patients: challenges and perspectives. , 2010, Trends in molecular medicine.
[11] K. Fung,et al. Detection of circulating tumor cells in advanced head and neck cancer using the cellsearch system , 2012, Head & neck.
[12] W. Gianni,et al. Chemosensitivity profile assay of circulating cancer cells: prognostic and predictive value in epithelial tumors , 2010, International journal of cancer.
[13] G. Berx,et al. The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. , 2005, Cancer research.
[14] Bo Lu,et al. 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood , 2011, Biomedical microdevices.
[15] Tanja Fehm,et al. HER-2 gene amplification can be acquired as breast cancer progresses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[16] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[17] K. Pantel,et al. Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer , 2009, Clinical Cancer Research.
[18] C. Punt,et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[19] Bo Lu,et al. A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter. , 2010, Cancer research.
[20] M. Golightly,et al. Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients , 2010, International journal of cancer.
[21] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .
[22] T. Molina,et al. Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker , 2010, Clinical Cancer Research.
[23] F. Chiappini,et al. Circulating Tumor Cells Measurements in Hepatocellular Carcinoma , 2012, International journal of hepatology.
[24] Mehmet Toner,et al. Detection of mutations in EGFR in circulating lung-cancer cells. , 2008, The New England journal of medicine.
[25] B. Naume,et al. Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern , 2011, Breast Cancer Research and Treatment.
[26] Robert Rosenberg,et al. Detection of circulating tumor cells in blood using an optimized density gradient centrifugation. , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[27] Kristine Broglio,et al. Circulating tumor cells in metastatic breast cancer , 2008, Cancer.
[28] B. Rack,et al. Hormone receptor status, erbB2 expression and cancer stem cell characteristics of circulating tumor cells in breast cancer patients. , 2012, Histology and histopathology.
[29] Tania Nolan,et al. Quantification of mRNA using real-time RT-PCR , 2006, Nature Protocols.
[30] Alison Stopeck,et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.
[31] Daniel Birnbaum,et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.
[32] G. Hortobagyi,et al. 18F-FDG PET/CT Findings and Circulating Tumor Cell Counts in the Monitoring of Systemic Therapies for Bone Metastases from Breast Cancer , 2010, The Journal of Nuclear Medicine.
[33] K. Schütze,et al. Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. , 2000, The American journal of pathology.
[34] Leon W.M.M. Terstappen,et al. Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer , 2006, Clinical Cancer Research.
[35] L. Frati,et al. Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[36] Jia Fan,et al. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance , 2011, Journal of Cancer Research and Clinical Oncology.
[37] Massimo Cristofanilli,et al. Considerations in the development of circulating tumor cell technology for clinical use , 2012, Journal of Translational Medicine.
[38] S. Indraccolo,et al. M30 Neoepitope Expression in Epithelial Cancer: Quantification of Apoptosis in Circulating Tumor Cells by CellSearch Analysis , 2010, Clinical Cancer Research.
[39] M. Rugge,et al. Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer , 2012, British Journal of Cancer.
[40] Ruud H. Brakenhoff,et al. Detection, clinical relevance and specific biological properties of disseminating tumour cells , 2008, Nature Reviews Cancer.
[41] J. Pouysségur,et al. Hypoxia signalling in cancer and approaches to enforce tumour regression , 2006, Nature.
[42] E. Lianidou,et al. Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay. , 2011, Clinical chemistry.
[43] S. Minner,et al. Detection of circulating tumour cells in peripheral blood of patients with advanced non‐metastatic bladder cancer , 2011, BJU international.
[44] Mehmet Toner,et al. Circulating tumor cells: approaches to isolation and characterization , 2011, The Journal of cell biology.
[45] A. Farcomeni,et al. Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[46] A. Vincent-Salomon,et al. Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[47] Klaus Pantel,et al. Cell-free nucleic acids as biomarkers in cancer patients , 2011, Nature Reviews Cancer.
[48] G. Hortobagyi,et al. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] I. Fidler,et al. Metastasis: Quantitative Analysis of Distribution and Fate of Tumor Emboli Labeled With 125I-5-Iodo-2′ -deoxyuridine , 1970 .
[50] Katharina Pachmann,et al. Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC® is a predictor for relapse: A preliminary report , 2005, World journal of surgical oncology.
[51] R C Coombes,et al. Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment , 2008, British Journal of Cancer.
[52] John Condeelis,et al. Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.
[53] M. Ignatiadis,et al. Minimal residual disease and circulating tumor cells in breast cancer , 2011, Breast Cancer Research.
[54] Yong‐Nyun Kim,et al. Anoikis Resistance: An Essential Prerequisite for Tumor Metastasis , 2012, International journal of cell biology.
[55] K. Pantel,et al. Circulating tumor cells and circulating tumor DNA. , 2012, Annual review of medicine.
[56] G. Doyle,et al. Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer , 2009, Journal of oncology.
[57] H. Groen,et al. Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[58] S. Groshen,et al. Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells , 2010, Clinical Cancer Research.
[59] K. Luzzi,et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. , 1998, The American journal of pathology.
[60] T. Fehm,et al. Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial , 2010, Clinical Cancer Research.
[61] T. Fehm,et al. Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status , 2007, Breast Cancer Research.
[62] H. Kuerer,et al. Circulating tumour cells in non-metastatic breast cancer: a prospective study. , 2012, The Lancet. Oncology.
[63] N. Tsubota,et al. Circulating Tumor Cell as a Diagnostic Marker in Primary Lung Cancer , 2009, Clinical Cancer Research.
[64] E. Lianidou,et al. Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment , 2012, Cancer and Metastasis Reviews.
[65] A. Nalla,et al. Oncogenic role of p53 is suppressed by si-RNA bicistronic construct of uPA, uPAR and cathepsin-B in meningiomas both in vitro and in vivo. , 2011, International journal of oncology.
[66] L. Ellis,et al. Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines , 2006, Clinical Cancer Research.
[67] Siyang Zheng,et al. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. , 2007, Journal of chromatography. A.
[68] L. V. van't Veer,et al. The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients , 2011, Breast Cancer Research.
[69] J. Thiery,et al. Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[70] I. Macdonald,et al. Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.
[71] Samy Lamouille,et al. TGF-β-induced epithelial to mesenchymal transition , 2009, Cell Research.
[72] R. Fodde,et al. Cancer stemness and metastasis: therapeutic consequences and perspectives. , 2010, European journal of cancer.
[73] Katharina Pachmann,et al. Standardized quantification of circulating peripheral tumor cells from lung and breast cancer , 2005, Clinical chemistry and laboratory medicine.
[74] J. Thiery,et al. Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.
[75] G. Z. Cheng,et al. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. , 2007, Cancer research.
[76] A. Adjei,et al. Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor , 2007, Clinical Cancer Research.
[77] Caroline Dive,et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[78] S. Digumarthy,et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.
[79] Anne Vincent-Salomon,et al. Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial , 2008, Clinical Cancer Research.
[80] Brigitte Rack,et al. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System , 2007, Clinical Cancer Research.
[81] Michael Koutsilieris,et al. Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis , 2011, BMC Cancer.
[82] R. Weinberg,et al. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.
[83] Giuseppe Naso,et al. Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients , 2011, Breast Cancer Research and Treatment.
[84] Paraskevi Giannakakou,et al. Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device , 2012, PloS one.
[85] E. Ozkan. Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: A review , 2011, Molecular and Cellular Endocrinology.
[86] Tanja Fehm,et al. Circulating Tumor Cells in Patients with Breast Cancer Dormancy , 2004, Clinical Cancer Research.
[87] J. Nesland,et al. Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer , 2006, International journal of cancer.
[88] Ryoji Kato,et al. Expected clinical applications of circulating tumor cells in breast cancer. , 2011, World journal of clinical oncology.
[89] J. Izbicki,et al. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. , 1993, Journal of the National Cancer Institute.
[90] J. Bono,et al. All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[91] G. T. Budd,et al. Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival , 2006, Clinical Cancer Research.
[92] C. Alix-Panabières. EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients. , 2012, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[93] M. Ducreux,et al. Disseminated and circulating tumor cells in gastrointestinal oncology. , 2012, Critical reviews in oncology/hematology.
[94] S. Agelaki,et al. Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[95] K. Pienta,et al. Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer , 2008, Clinical Cancer Research.
[96] J. Aguirre-Ghiso,et al. Models, mechanisms and clinical evidence for cancer dormancy , 2007, Nature Reviews Cancer.
[97] K. Isselbacher,et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip , 2010, Proceedings of the National Academy of Sciences.
[98] H. Kajiyama,et al. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. , 2007, International journal of oncology.
[99] P. Kober,et al. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay. , 2004, Acta biochimica Polonica.
[100] C. Klein,et al. Parallel progression of primary tumours and metastases , 2009, Nature Reviews Cancer.
[101] E. Lianidou,et al. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges. , 2011, Clinical chemistry.
[102] R. Bast,et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[103] R. Weinberg,et al. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. , 2012, Seminars in cancer biology.